Hyaluronic acid market seen reaching $2.1 billion by 2030

Allied Market Research says the global hyaluronic acid market will grow from $1.0 billion in 2020 to $2.1 billion by 2030, driven by cosmetic uses, nonsurgical procedures and pharmaceutical demand. Asia-Pacific and the pharmaceutical segment are expected to lead growth through the end of the decade.

Why it matters: - Hyaluronic acid is expanding across cosmetics, pharmaceuticals and nutraceuticals, giving suppliers exposure to multiple end markets. - The market forecast points to long-term demand growth, especially in products tied to beauty, joint care and medical uses. - The report flags technological advances as a future opportunity, which could shape product development and pricing.

What happened: - Allied Market Research published a report on the global hyaluronic acid market covering 2021 to 2030. - The market generated $1.0 billion in 2020 and is projected to reach $2.1 billion by 2030. - The forecast implies an 8.1% CAGR from 2021 to 2030. - The report covers end-use industries, market trends, volume and revenue, and the impact of COVID-19. - The report includes a sample download, an enquiry page and a full summary report: Sample of the report, purchase enquiry, purchase options and full summary report.

The details: - High benefits in the cosmetic industry and rising adoption of nonsurgical cosmetic procedures are identified as key growth drivers. - Competition from alternative ingredients is identified as a restraint on market growth. - The pharmaceutical industry segment held more than half of global revenue in 2020. - The pharmaceutical segment is expected to remain the leading end-use category through 2030. - The pharmaceutical segment is projected to grow at an 8.5% CAGR from 2021 to 2030, helped by favorable government policies in several regions. - The cosmetic and nutraceutical industries are also included in the market analysis. - Asia-Pacific, followed by North America, held more than four-fifths of global revenue in 2020. - Asia-Pacific is expected to post the fastest CAGR at 8.3% through 2030. - The regional outlook cites established consumer bases in pharmaceuticals and cosmetics as the main support for that growth. - The report also covers North America, Europe and LAMEA. - Leading market players listed in the report include Contipro a.s., Landec Corporation, Anmol Chemicals Group, Kewpie Corporation, Shandong Topscience Biotech Co., Ltd., Liuzhou Shengqiang Biotech Co., Ltd., Shijiazhuang lateen chemical co., ltd., Shandong Focuschem Biotech Co., Ltd., Tiansheng Bio and Kikkoman Biochemifa Company.

Between the lines: - The strongest growth is concentrated in medical and beauty applications, which suggests hyaluronic acid demand is becoming more diversified and less dependent on a single use case. - Regional leadership in Asia-Pacific and the pharmaceutical segment suggests the market is being shaped by established manufacturing, consumer demand and policy support. - The presence of alternatives remains the clearest headwind, so market share gains may depend on cost, performance and formulation improvements.

What’s next: - The report expects technology improvements to create new opportunities over the forecast period. - Asia-Pacific is expected to keep its lead through 2030 while North America remains the second-largest region. - The pharmaceutical segment is expected to stay the largest end-use category as demand rises across medical applications. - More details are available in the company’s announcement: For more details.